KEGG MEDICUS Search Result |
Top |
Entry | Name | Name(TN) | Disease |
---|---|---|---|
D11067 | Ertugliflozin and metformin | Segluromet (TN) | Type 2 diabetes mellitus [DS:H00409] |
D11068 | Letrozole and ribociclib | Kisqali femara (TN) | Breast cancer (HR positive, HER2 negative) [DS:H00031] |
D11069 | Amlodipine and benazepril |
Amlobenz (TN) Lotrel (TN) |
Hypertension [DS:H01633] |
D11070 | Tirabrutinib hydrochloride (JAN/USAN) | Velexbru (TN) | |
D11071 | Dotinurad (JAN/INN) | Urece (TN) | |
D11072 |
Siponimod fumarate (USAN) Siponimod fumaric acid (JAN) |
Mayzent (TN) | Multiple sclerosis [DS:H01490] |
D11073 |
Tepotinib hydrochloride (USAN) Tepotinib hydrochloride hydrate (JAN) |
Tepmetko (TN) | Non-small cell lung cancer (MET exon 14 skipping) [DS:H00014] |
D11074 | Ipatasertib hydrochloride (JAN) | ||
D11075 | Chlorpheniramine and hydrocodone |
Tussicaps (TN) Tussinonex (TN) |
|
D11076 | Homatropine meylbromide and hydrocodone | Tussigon (TN) | |
D11077 |
Pegvaliase (INN) Pegvaliase (genetical recombination) (JAN) Pegvaliase-pqpz |
Palynziq (TN) | Phenylketonuria [DS:H00167] |
D11078 | Vadadustat (JAN/USAN/INN) | Vafseo (TN) | Anemia due to chronic kidney disease [DS:H01642] |
D11079 |
Satralizumab (USAN/INN) Satralizumab (genetical recombination) (JAN) satralizumab-mwge |
Enspryng (TN) | Neuromyelitis optica spectrum disorder (anti-AQP4 antibody positive) [DS:H01491] |
D11080 |
Nemolizumab (USAN/INN) Nemolizumab (genetical recombination) (JAN) |
Mitchga (TN) | |
D11081 |
Febuxostat hydrate (JAN) Febuxostat hemihydrate |
||
D11082 |
Anifrolumab (USAN) Anifrolumab (genetical recombination) (JAN) Anifrolumab-fnia |
Saphnelo (TN) | Systemic lupus erythematosus [DS:H00080] |
D11083 |
Brolucizumab (USAN/INN) Brolucizumab (genetical recombination) (JAN) Brolucizuab-dbll |
Beovu (TN) | Age-related macular degeneration [DS:H00821] |
D11084 | Clindamycin phosphate and tretinoin |
Veltin (TN) Ziana (TN) |
Acne vulgaris [DS:H01445] |
D11085 | Trimethoprim hydrochloride |
Primsol (TN) Trimpex (TN) |
Uncomplicated urinary tract infections [DS:H01176] |
D11086 | Polymyxin B and trimethoprim | Polytrim (TN) | Bacterial conjunctivitis [DS:H01366] |
D11087 | Hydrocodone and guaifenesin | Flowtuss (TN) | |
D11088 | Chlorpheniramine maleate, hydrocodone bitartrate and pseudoephedrine | Zutripro (TN) | |
D11089 | Ciprofloxacin hydrochloride and fluocinolone acetonide | Otovel (TN) | |
D11090 | Ivosidenib (JAN/USAN/INN) | Tibsovo (TN) | Acute myeloid leukemia (susceptible IDH1 mutation) [DS:H00003] |
D11091 | Diclofenac sodium and misoprostol | Arthrotec (TN) | Rheumatoid arthritis [DS:H00630] |
D11092 | Pitavastatin magnesium | Zypitamag (TN) |
Primary hyperlipidemia [DS:H01635] Mixed dyslipidemia [DS:H01635] |
D11093 | Avacopan (JAN/USAN/INN) | Tavneos (TN) | |
D11094 |
Lanadelumab (USAN) Lanadelumab (genetical recombination) (JAN) Lanadelumab-flyo |
Takhzyro (TN) | Hereditary angioedema [DS:H01006] |
D11095 | Atorvastatin calcium propylene glycol solvate | Hyperlipidemia [DS:H01635] | |
D11096 | Neomycin and polymyxin B sulfate | ||
D11097 | Polymyxin B sulfate and bacitracin zinc | Polycin (TN) |
Bacterial conjunctivitis [DS:H01366] Blepharitis [DS:H01644] |
D11098 | Telenzepine hydrochloride hydrate (JAN) | ||
D11099 | Nebracetam fumarate (JAN) | ||
D11100 | Sepimostat mesilate (JAN) | ||
D11101 | Danofloxacin mesilate hydrate (JAN) | ||
D11102 | Tamolarizine hydrochloride (JAN) | ||
D11103 | Batebulast hydrochloride (JAN) | ||
D11104 |
Vinconate hydrochloride (JAN) Vinconate monohydrochloride |
||
D11105 | Osaterone acetate (JAN) | ||
D11106 | Filgotinib maleate (JAN/USAN) | Jyseleca (TN) |
[ KEGG | NETWORK | DISEASE | DRUG | MEDICUS ] |